Ambria Dermatology is a research and development company focused on technological solutions for the dermatological science sector.
Ambria Dermatology AB, a research and development company, focuses on solutions in dermatology science. It offers technology platform, which includes pentane-1,5-diol delivery platform for the dermal delivery of topically applied pharmaceuticals, cosmeceuticals, and products for technical use. The company is based in Helsingborg, Sweden. As of October 30, 2009, Ambria Dermatology AB operates as a subsidiary of Natumin Pharma AB.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 20, 2006 | Series Unknown | kr5M | 1 | Innovationsbron Väst Startup AB | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innovationsbron Väst Startup AB | Yes | Series Unknown |